Objective: To study associations of the severity of impairment in childhood neurocognition (NC) with long-term mortality and complete seizure remission. Methods: A population-based cohort of 245 subjects with childhood onset epilepsy was followed up for 50 years (median = 45, range = 2-50). Childhood NC before age 18 years was assessed as a combination of formal intelligence quotient 10YTR was highest among subjects with normal NC (61%), whereas none of those with profound impairment reached 10YTR. In the intermediate categories, the chance was, however, not directly related to the increasing severity of impairment. Significance: The severity of neurocognitive impairment during childhood shows a parallel increase in the risk of death. In comparison with normal NC, subjects with lower childhood NC are less likely to enter seizure remission. However, normal NC does not guarantee complete remission or prevent premature death in some individuals with childhood onset epilepsy.
| INTRODUCTION
It is well-known that intellectual disability (ID) is associated with premature mortality 1, 2 and unfavorable seizure outcome. 1, 3, 4 Although a few studies on the association of the severity of ID with increase in the risk for premature death exist, [5] [6] [7] [8] none of them discusses that effect in the childhood onset epilepsy population. Our large, 50-year prospective follow-up study of mortality and seizure remission off antiepileptic drugs in people with childhood onset epilepsy in relation to neurocognition (NC) before age 18 years is, to our knowledge, the first population-based study to use NC as a predictor of long-term outcomes in epilepsy.
Our objective was to examine premature mortality and seizure remission in relation to NC in subjects with childhood onset epilepsy. We hypothesized that people with more severe ID or, more comprehensively, more impaired NC before age 18 years would have more frequent premature death and fewer terminal remissions than subjects with less impaired NC.
| MATERIALS AND METHODS
The study subjects included all children aged 0-15 years who were resident in the catchment area of Turku University Hospital, Turku, Finland and who, during 1961-1964, met the criteria for epilepsy (two unprovoked seizures). 9 Subjects were identified from the patient records of all relevant primary health care units and hospitals, and from a review of the National Health Service records, a register of all patients residing in Finland. In Finland, as a rule, all children with an epileptic seizure were hospitalized for evaluation. [10] [11] [12] Altogether, 245 (132 boys and 113 girls) children were identified, 91% of them from Turku University Hospital and the remaining 9% from other hospitals, institutions, and public or private offices. An ongoing surveillance for 5 years revealed three relevant patients, who were lost to identification and subsequently not included in our study. Thus, our study subjects cover virtually all the children with active epilepsy in the study area in 1961-1964. Of 245 patients, 150 (61%) were incident cases, that is, they were for the first time evaluated for epilepsy in 1961-1964. The remaining 95 patients (39%) were prevalent cases with active epilepsy, that is, they had been seen for epilepsy before 1961, and had had at least one seizure in the 3 years prior to or during the years 1961-1964. Data collection of all the patients started from first diagnosis. All 245 patients were examined at baseline by the same child neurologist 9 and enrolled for prospective follow-up of medical and social outcomes. By written informed consent, ongoing review of the medical records and a comprehensive evaluation with structured questionnaires in 5-year intervals were performed. The study design and has been reported previously. 10, [13] [14] [15] [16] For the present study, seizure outcome data were up to 2007. Death data were derived from the national Death Register up to December 31, 2010.
Intelligence quotient (IQ) assessments were not routinely performed at onset of epilepsy. The subset of IQscored subjects was not a random but a selected sample overrepresenting the children with suspected neurocognitive impairment. Therefore, to gauge overall intellectual ability, an objective system to classify neurocognitive functioning was devised. The categorization of NC was made with respect to definitions of intellectual functioning in the International Classification of Diseases, 10th revision (R41.83, F70-F73) combining (1) IQ level, if available; (2) basic and vocational education; (3) occupational status at age 18 years; and (4) records of psychoneurological development and status during childhood. The criteria other than formal IQ assessment are henceforth referred to as "functional criteria." Basically, normal NC was defined as a full-scale IQ score of ≥85 based on contemporary IQ test(s) or psychological assessment of normality with no clinical grounds for formal testing, and passing mainstream basic education (ie, common grade school) complemented with either academic or vocational education or straightforward transition to working life. Participants with borderline NC had an IQ of 70-84 and had passed mainstream or "adapted" basic education but were not in regular work or on disability pension. Participants who had an IQ of 50-69, had passed adapted basic education, and were granted a disability pension before age 18 years by the Social Insurance Institution were categorized as mildly impaired. An IQ of 35-49, individualized or no basic education, and disability pension implied a moderate impairment. Subjects with a severe impairment had an IQ of 20-34, no individualized or adapted education, disability pension, and abnormal psychoneurological development and developmental status. 17, 18 Patients with an IQ of <20 and those considered not
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• All-age mortality is directly related to childhood NC level in 50-year follow-up of childhood onset epilepsy • Long-term seizure remission off antiepileptic drugs is associated with childhood NC level • Normal NC does not guarantee complete remission or prevent premature death in childhood onset epilepsy • Measures of NC other than IQ (development, educational attainment, and employability) are well in agreement with IQ testable due to virtually no intellectual contact or communication ability were assessed as having a profound neurocognitive impairment. The IQs of the subjects were based on the following data: (1) formal testing and assessment made by a psychologist, result given as full-scale IQ scores (n = 119); (2) formal testing and assessment made by a psychologist, with the result not given in scores, but verbally and categorized as normal or impaired (borderline, mild, moderate, severe, profound; n = 28); (3) no formal testing and no need for testing due to sufficient evidence of normal IQ, as assessed by a psychologist (n = 58); and (4) no testing or assessment by a psychologist, obviously normal IQ as assessed by physician (n = 35) and no data on IQ level (n = 5).
To check the internal consistence of IQ and the selected functional criteria, a rating of NC based on the pure functional criteria was done using an algorithm that screened the database, ignoring any other information than that listed above in NC items 2-4. After exclusion of five subjects with missing IQ data and four with missing functional data, among the remaining 236 subjects 190 (81%) had concordant ratings by both the IQ and the functional criteria. Of the discordant ratings, 31 (13%) were assessed lower and 15 (6%) higher by the IQ than the functional criteria. The overall agreement between the IQ and the functional criteria-based ratings was excellent (κ = 0.90, 95% confidence interval [CI] = 0.88-0.93).
The classification of NC was conducted by two independent raters. For those with discordant NC ratings based on IQ and functional criteria, the review of individual patient data was extended from the IQ and functional criteria to delivery history, neurological and psychiatric morbidity, disabilities, reports on medical and neuropsychological examinations, and social capability. The kappa value between the raters was very high (κ = 0.93, 95% CI = 0.87-0.99), indicating "almost perfect agreement." 19 Any discrepancies between the raters were reevaluated in a consensus meeting. The raters, relying on data on NC before 18 years, were blinded to mortality and remission status of the participants, except for those who died before 1972.
The outcome variables were all-cause mortality and 10-year complete remission, the latter defined as seizure freedom for the past 10 years with the past 5 years without medication. 20 
| Statistics
The proportions of patients within different NC categories were tested with Cochran-Mantel-Haenszel χ 2 tests for row mean score differences. Mortality and seizure outcomes were analyzed with left-truncated univariate and multivariate Cox regression models, and the results are presented as hazard ratios with Bonferroni corrected 95% CIs. The multivariate models included sex, cerebral palsy, status epilepticus, and age at onset of epilepsy < 6 years as covariates. The proportionality of the hazards was checked using supremum tests. P values < 0.05 were considered significant. All tests were two-sided. Statistical computations were done using SAS System for Windows, release 9.4 (SAS Institute). The study design was approved by the institutional review board (ETMK 120/180/2008).
| RESULTS
Of our prospective long-term population cohort of 245 children with epilepsy (including 150 incidence cases), 119 (49%) had normal NC, whereas 126 (51%) had various degrees of neurocognitive impairment. The median followup of the cohort was 45 years (mean = 39.0, SD = 13.3, range = 2-50).
| Mortality
During the total observation period, 71 (29%) of all 245 subjects (13% of 119 with normal and 44% of 126 subjects with impaired NC) died. On follow-up of 50 years, the allcause mortality rate was 7.3 per 1000 patient-years among all subjects, and 11.9 per 1000 patient-years in those with impaired NC. Approximately half the deaths were epilepsyrelated (Table 1 ). All covariates in the Cox model were nonsignificant (P > 0.1) and were excluded from the analysis. In comparison to subjects with normal NC, the hazard of death increased by approximately one unit on each step toward lower cognition, reaching significance in moderate or more severe impairment versus normal NC (Table 2) . From the first decade of the diagnosis of epilepsy, mortality dramatically increased among subjects with more severely impaired NC from that among subjects with normal or borderline impaired NC (Figure 1 ). Table 3 shows that one-half died from epilepsy-related and the other half from non-epilepsy-related causes. The spectrum of causes of death varied in the different NC categories. In subjects with normal NC (n = 16), sudden unexpected death in epilepsy (SUDEP) was the most frequent cause of death (39%), followed by vascular disease (25%) and cancers (25%). Subjects with mild impairment (n = 10) mostly died from SUDEP (40%) or cancers (20%) and moderately impaired subjects (n = 9) from infection of the lower respiratory tract (44%) or SUDEP. Half of those with severe impairment (n = 6) died from vascular diseases. The most frequent causes of death among subjects with profound impairment (n = 28) were respiratory infection (mostly lower respiratory tract; 39%), SUDEP (32%), status epilepticus (14%), and vascular disease (11%). The proportion of SUDEP decreased from 39% for subjects with normal or borderline NC to 37% for mild to moderate impairment and further to 28% for severe to profound impairment. Respiratory infection was strongly associated with profound neurocognitive impairment.
| Seizure remission
Chances for entering 10-year complete remission with the past 5 years off antiepileptic drugs (10YTR) were highest among subjects with normal NC (61%), whereas none of those with profound impairment reached 10YTR. In the intermediate categories, the chances were, however, not directly related to increasing severity of impairment (Table 1 ). The hazard ratios for normal versus lower NC ranged from threefold in normal NC versus mild impairment to over sixfold in normal NC versus moderate impairment. The fourfold hazard ratio between normal NC and severe impairment was nonsignificant. Huge hazard ratios were detected in normal NC when compared to the profoundly impaired, none of whom reached 10YTR (Table 2) .
During long-term follow-up of 50 years, 10 (8%) subjects with normal NC stopped having seizures within the first year and 38 (53%) within the first 5 years after diagnosis, and entered subsequent 10YTR on 11-16 years of follow-up. Of subjects with impaired NC, all had ongoing seizures for >1 year, and only four (12%) mildly impaired and one of the 10 severely impaired subjects became seizure-free during the first 5 years after diagnosis and thus entered 10YTR before or during the 16th follow-up year (Figure 2 ).
| DISCUSSION
In this large, 50-year prospective follow-up study, we found the risk of death to gradually increase in relation to lower NC before age 18 years. Chances for remission were T A B L E 1 Characteristics and medical outcomes of 245 subjects with childhood onset epilepsy by childhood neurocognition significantly reduced in all degrees of NC, but not in the order of severity. Our study is, to our knowledge, the first populationbased study to use NC as a predictor of long-term outcomes in epilepsy. Overall cognitive functioning is increasingly preferred to ID and its precedent, mental retardation. [21] [22] [23] [24] NC as used here is considered a more comprehensive construct than exclusive reliance on IQ as a benchmark for NC. [25] [26] [27] Nonetheless, formal and unified IQ tests for any patient with onset of epilepsy would be an ideal design for the determination of neurocognitive function. However, at the shift of the 1940/1950s to early 1960s, that is, the years of birth of our study subjects, the regular application of formal tests to all patients with epilepsy was very unusual if not needed for other reasons related to epilepsy (eg, school placement or health care benefits). In the absence of the baseline IQs, we devised an index of NC that included full-scale IQs (when available) combined with the functional criteria as reported above. The assessments of the two independent raters were in almost perfect consensus (κ = 0.93), supporting the view that this appears to be a reliable metric. The overall mortality in our study (43%) is comparable with 41%-48% of similar studies. 28, 29 Furthermore, our previously 30 reported overall standardized mortality ratio (6.4) of the present cohort is well comparable with 6.4-9.7 from other prospective population or community studies. [31] [32] [33] The severity of neurocognitive impairment during childhood showed a parallel increase in the risk of death. The few previous papers on the association of childhood intelligence with long-term outcomes of several long-term diseases other than epilepsy are consistent with our study. A meta-analysis of 16 unrelated prospective cohort studies with follow-up of 17-69 years 6 revealed a positive association between intelligence in youth and all-cause mortality, with a 24% reduction in the risk of death for 1-SD increase in IQ. The association was not confounded by childhood or adult age socioeconomic status. In a Scottish whole-population survey, 8 65 765 schoolchildren born in 1936 completed in 1947 a general intelligence test and cases of death in the cohort were recorded at 68-year follow-up. Lower childhood intelligence (by 10th percentile or quarters) was related to higher cause-specific mortality. The age-and sex-adjusted hazard ratios were strongest for respiratory disease, coronary heart disease, stroke, injury, smokingrelated cancers, digestive disease, and dementia. Deaths from epilepsy were not reported. After adjustment for potential confounders, including socioeconomic status, only slight attenuation of the estimated effect of intelligence was observed. Whalley and Deary 5 followed about 2800 | 135 schoolchildren up to age 76 years and found an increase in overall mortality in parallel to lower IQ at school age. In another paper, 7 about 4500 adults aged >55 years were followed for survival/death for 17 years. They found a gradient of increased risk for all-cause mortality associated with severity of cognitive impairment. An interesting association has been reported between childhood cognitive function and inflammation in middle age. In 4256 young men enrolled from Vietnam era US veterans, after adjustment for age and circumstantial, sociodemographic, lifestyle, and health factors, a lower cognitive ability was found to be associated with a higher erythrocyte sedimentation rate, a marker of inflammation, in middle age. 34 Calvin et al 6 measured blood concentrations of midlife blood biomarkers including C-reactive protein, D-dimer, fibrinogen, and von Willebrand factor antigen in 9377 males and females and found significant inverse associations with childhood intelligence; however, this was largely explained by health behavior. The associations were accounted for 24%-44% by parental socioeconomic status in early life, largely attenuating the effects (84%-100%) when adjusted for adult cardiovascular risk factors. The significant inverse associations between the biomarkers and cognitive tests taken at age 50 years could be accounted for by 50%-100% attenuation by childhood intelligence. In our cohort, SUDEP was the leading cause of death. Its role was greatest in subjects with normal NC or less severe impairment, whereas lower respiratory tract infection was the most frequent cause in profound neurocognitive impairment. Neither status epilepticus, drowning, nor suicide emerged as an important cause.
Neurocognition
People with ID are, in comparison with people of normal intelligence, at increased risk for epilepsy ranging from 23% to 33% in population-based ID studies. [35] [36] [37] However,
we found no data on the association between lower F I G U R E 2 Proportion of subjects with childhood onset epilepsy (n = 245) in 10-year terminal remission with 5 last years off medication by childhood neurocognition impairment level childhood intelligence and lower chance for remission. Although we found the degree of impairment in childhood intelligence to be a predictor of the risk of death, we failed to show a direct gradient between childhood intelligence and remission. However, normal NC did not guarantee complete remission or prevent premature death in individuals with childhood onset epilepsy. The implications of these results are: (1) childhood NC is inversely related to the risk of death; (2) the severity of neurocognitive impairment is not directly related to terminal remission, but any impairment reduces the chance for remission compared to subjects with normal NC; and (3) remission, if any, appears earlier in subjects with normal than with impaired childhood NC.
There are some limitations to our study. Patients with prevalent epilepsy who died or entered remission before the study period could not, by definition, be included in our study. Such truncation probably excluded cases with favorable outcome from the less severe groups, whereas early deaths most likely have occurred among the more severe patients. However, if this assumption is valid, consideration of those cases would only have strengthened the inverse trend between neurocognitive abilities and mortality found in this study, and thus the underestimation does not invalidate our results. At the onset of the study, modern neuroimaging technology and pharmacotherapy were not available. As a consequence, the underlying cause of course cannot be addressed but is likely to be relevant both to cognitive impairment and lack of terminal remission in the impaired group. Conversely, the attributive effect of modern antiepileptic drugs on seizure remission is disappointingly slight. 38 As in most similar long-term studies, we had no unified neuropsychological test battery that was performed at or before onset of epilepsy. Therefore, we needed to devise an operational definition of NC as reported. Although this may have limitations, it predicts important life outcomes and is consistent with standard indicators of IQ. Half a century ago, epilepsy surgery in general, and for children and the "mentally handicapped" in particular, was not accessible to the same extent as today. The strengths of our study include prospective and ultralong follow-up of 50 years, and a fixed and stable population representative of the study area. We had a comprehensive dataset of delivery history and neurodevelopmental profile, psychometrics based on contemporary test methods, school education, and achievement to enable assessment of the neurocognitive function of our study subjects.
| CONCLUSIONS
Assessing NC in patients with childhood onset epilepsy provides clinically useful information indicating that there is a gradual increase in the mortality risk parallel to declining NC. The increase is significant in subjects with moderate to profound impairment. Although the severity of neurocognitive deficits is not directly related to failed complete remission, any impairment reduces the chance for remission compared to normal NC.
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